Vancouver, Canada

Paulo Jia Ching Lin

This inventor holds 2 USPTO granted patents and 9 published patent applications and 2 EPO patents. Top assignee: Acuitas Therapeutics, Inc.. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paulo Jia Ching Lin. Retrieved from https://idiyas.com/inventor/paulo-jia-ching-lin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Paulo Jia Ching Lin

Introduction

Paulo Jia Ching Lin is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of lipid nanoparticle formulations, which are crucial for the delivery of therapeutic agents. His work has the potential to impact various medical applications.

Latest Patents

Paulo holds one patent related to improved formulations of lipid nanoparticles. This patent provides methods for the preparation of these nanoparticles and their use in delivering therapeutic agents effectively. His innovative approach enhances the efficacy of drug delivery systems.

Career Highlights

Paulo Jia Ching Lin is associated with Acuitas Therapeutics, Inc., where he applies his expertise in lipid nanoparticle technology. His role at the company allows him to contribute to cutting-edge research and development in the pharmaceutical industry.

Collaborations

He has collaborated with notable colleagues, including Michael J Hope and Barbara Mui. These partnerships foster a collaborative environment that enhances the innovation process.

Conclusion

Paulo Jia Ching Lin's work in lipid nanoparticle formulations exemplifies the importance of innovation in therapeutic delivery systems. His contributions are paving the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…